@ImagionBio
Please, ask your colleagues to read the pilot study updates delivered by EMVision (EMV) and discuss whether there could be any value in adapting our trial update announcements. They need to be clear and informative.
Below is an example, their first trial update from July 2020:
Much appreciated and kind regards,
A fellow shareholder.
Feedback for IBX management
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| IBX (ASX) Chart |
Day chart unavailable